Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Positive Results from Six-Month Phase 2 Trial of Mavorixafor in ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic ...

Research shows some of the most common short-term effects include nausea, vomiting, abdominal pain, constipation, increased ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

People who have nausea, vomiting, diarrhea, stomach cramps or other symptoms ... immunocompromised people and others who have severe underlying chronic conditions. They should take extra ...

They can also slash risks of heart attack, stroke, and chronic disease ... to experience at least mild gastrointestinal ...

"If you don't have much interest in eating or sleeping so much you are missing meals, you are going to lose weight," ...

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s disease. Here's what your doctor may recommend.

These cellular alterations can cause organ damage, leading to chronic diseases ... effects reported with curcumin include diarrhea, headache, rash, nausea, and yellow stool.